P412 A patient-led review of outpatient services following the COVID-19 pandemic and widespread introduction of highly-effective modulator treatments and remote monitoring devices

Abstract

Adult Cystic Fibrosis (CF) care has changed significantly over recent years. During the COVID pandemic, many clinics become “virtual.” Within months, highly effective modulator therapies (HEMT), such as Kaftrio, were approved for ~90% of adults with CF(AWCF) in the UK, significantly improving quality of life. This period has also seen increased use of remote monitoring of nebuliser adherence (CFHealthHub) and blood sugars (Libre).